Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:appointed_by |
gptkb:hospital
oral tablet |
| gptkbp:approves |
gptkb:1999
gptkb:FDA |
| gptkbp:brand |
gptkb:Liletta
gptkb:Plan_B gptkb:Skyla gptkb:Mirena Next Choice |
| gptkbp:contraindication |
gptkb:healthcare_organization
liver disease pregnancy |
| gptkbp:excretion |
urine
|
| gptkbp:financial_performance |
sodium chloride
magnesium stearate microcrystalline cellulose lactose monohydrate |
| https://www.w3.org/2000/01/rdf-schema#label |
levonorgestrel
|
| gptkbp:ingredients |
C21 H28 O2
|
| gptkbp:is_a |
progestin
|
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_available_on |
gptkb:drug
generic medication prescription medication |
| gptkbp:is_effective_against |
altering uterine lining
preventing ovulation thickening cervical mucus |
| gptkbp:is_part_of |
hormonal therapy
combination contraceptive pills contraceptive regimen hormonal IU Ds |
| gptkbp:is_related_to |
progesterone
contraceptive implants |
| gptkbp:is_used_by |
gptkb:philosopher
|
| gptkbp:is_used_for |
gptkb:drug
birth control |
| gptkbp:is_used_in |
fertility treatments
menstrual regulation menstrual cycle regulation endometriosis treatment hormonal replacement therapy postcoital contraception contraceptive injections dysmenorrhea treatment ovarian suppression |
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
headache
nausea breast tenderness irregular menstrual bleeding |
| gptkbp:bfsParent |
gptkb:Plan_B
gptkb:Mirena |
| gptkbp:bfsLayer |
4
|